Pete Davidson Reveals He's Tried Ketamine To Cope With Depression
Portfolio Pulse from Lara Goldstein
SNL star Pete Davidson has revealed he uses ketamine to treat his depression. Ketamine is often prescribed off-label for treating major depression and anxiety, among other conditions. Its FDA-approved format is Johnson & Johnson's (NYSE:JNJ) nasal spray, Spravato.
September 01, 2023 | 7:56 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The news about Pete Davidson using ketamine for depression could potentially increase the visibility and demand for Johnson & Johnson's ketamine-based product, Spravato.
The news about a high-profile individual like Pete Davidson using ketamine for depression could potentially increase the visibility and demand for ketamine-based products. As Johnson & Johnson is the manufacturer of the FDA-approved ketamine product, Spravato, this could potentially have a positive impact on the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80